142 related articles for article (PubMed ID: 9389918)
1. The bone isoenzyme of alkaline phosphatase in hypercalcaemic cancer patients.
Body JJ; Dumon JC; Blocklet D; Darte C
Eur J Cancer; 1997 Sep; 33(10):1578-82. PubMed ID: 9389918
[TBL] [Abstract][Full Text] [Related]
2. Comparison of assay of total and bone-specific alkaline phosphatase in the assessment of osteoblast activity in patients with metastatic bone disease.
Piovesan A; Berruti A; Torta M; Cannone R; Sperone P; Panero A; Gorzegno G; Termine A; Dogliotti L; Angeli A
Calcif Tissue Int; 1997 Nov; 61(5):362-9. PubMed ID: 9351876
[TBL] [Abstract][Full Text] [Related]
3. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
[TBL] [Abstract][Full Text] [Related]
4. Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases.
Woitge HW; Seibel MJ; Ziegler R
Clin Chem; 1996 Nov; 42(11):1796-804. PubMed ID: 8906079
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of simultaneous determination of bone alkaline phosphatase mass concentration in serum and urinary excretion of pyridinium cross-links for detection of bone metastases.
Withold W; Georgescu G; Khakzad H; Vosberg H; Mueller-Gaertner HW; Reinauer H
Clin Biochem; 1995 Oct; 28(5):511-9. PubMed ID: 8582050
[TBL] [Abstract][Full Text] [Related]
6. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
[TBL] [Abstract][Full Text] [Related]
7. Serum osteocalcin (BGP) in tumor-associated hypercalcemia.
Body JJ; Cleeren A; Pot M; Borkowski A
J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743
[TBL] [Abstract][Full Text] [Related]
8. Bone alkaline phosphatase in Paget's disease.
Deftos LJ; Wolfert RL; Hill CS
Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
[TBL] [Abstract][Full Text] [Related]
9. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
10. Measurement of bone specific alkaline phosphatase in the horse: a comparison of two techniques.
Jackson B; Eastell R; Russell RG; Lanyon LE; Price JS
Res Vet Sci; 1996 Sep; 61(2):160-4. PubMed ID: 8880988
[TBL] [Abstract][Full Text] [Related]
11. Tartrate-resistant acid phosphatase 5b activity is a useful bone marker for monitoring bone metastases in breast cancer patients after treatment.
Chung YC; Ku CH; Chao TY; Yu JC; Chen MM; Lee SH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):424-8. PubMed ID: 16537696
[TBL] [Abstract][Full Text] [Related]
12. Method for determination of bone alkaline phosphatase activity: analytical performance and clinical usefulness in patients with metabolic and malignant bone diseases.
Withold W; Schulte U; Reinauer H
Clin Chem; 1996 Feb; 42(2):210-7. PubMed ID: 8595712
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between levels of osteocalcin and bone alkaline phosphatase in healthy control and postmenopausal osteoporotic women.
Díaz Diego EM; Díaz Martín MA; de la Piedra C; Rapado A
Horm Metab Res; 1995 Mar; 27(3):151-4. PubMed ID: 7607606
[TBL] [Abstract][Full Text] [Related]
14. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours.
Schindler F; Lajolo PP; Pinczowski H; Fonseca FL; Barbieri A; Massonetto LH; Katto FT; Del Giglio A
Eur J Cancer Care (Engl); 2008 Mar; 17(2):152-6. PubMed ID: 18302652
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
Garnero P; Delmas PD
J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
[TBL] [Abstract][Full Text] [Related]
16. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity.
Mayne PD; Thakrar S; Rosalki SB; Foo AY; Parbhoo S
J Clin Pathol; 1987 Apr; 40(4):398-403. PubMed ID: 3584482
[TBL] [Abstract][Full Text] [Related]
17. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
Charles P; Poser JW; Mosekilde L; Jensen FT
J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
[TBL] [Abstract][Full Text] [Related]
18. Serum bone alkaline phosphatase and CA 549 in breast cancer with bone metastases.
Cooper EH; Forbes MA; Hancock AK; Parker D; Laurence V
Biomed Pharmacother; 1992; 46(1):31-6. PubMed ID: 1421033
[TBL] [Abstract][Full Text] [Related]
19. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen.
Morote J; Lorente JA; Encabo G
Cancer; 1996 Dec; 78(11):2374-8. PubMed ID: 8941009
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis.
Takahashi M; Kushida K; Hoshino H; Miura M; Ohishi T; Inoue T
Clin Endocrinol (Oxf); 1997 Aug; 47(2):177-83. PubMed ID: 9302392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
